Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NETWORK 1FED 1

Study Type

Interventional 1

Sponsor

Conditions

Rare Diseases 1Neurologic Manifestations 1Myasthenia Gravis 1Mental Disorders 1

Interventions

Capecitabine 2leucoselect phytosome 1gallium 68 PSMA-11 1Oxaliplatin 1Midazolam 1Ketamine 1Injections 1Immunoglobulins 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × FED × Immunoglobulins × Clear all
NCT00004682 2015-03-25

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

FDA Office of Orphan Products Development

Phase NA Terminated
100 enrolled

Mental Disorders, Myasthenia Gravis, Neurologic Manifestations, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡